fbpx
QQQ
+ 0.89
339.46
+ 0.26%
DIA
+ 0.07
344.91
+ 0.02%
SPY
+ 0.75
422.86
+ 0.18%
TLT
-0.23
142.77
-0.16%
GLD
-2.04
179.78
-1.15%

Why Is It Moving? Analyzing The Upward Movement in Aeterna Zentaris's Stock Today

April 26, 2021 1:30 pm
Share to Linkedin Share to Twitter Share to Facebook Share to Print License More

Aeterna Zentaris’s Stock Price And Volume Action

Aeterna Zentaris’s (NASDAQ:AEZS) stock is trading up 16.54% to a price of $1.09. The stock’s volume is currently 7.78 million, which is roughly 83.1% of its recent 30-day volume average of 9.36 million.

Why It’s Moving

Benzinga Pro’s real-time breaking news service shows some insight into what is affecting shares: Aeterna Zentaris shares are trading higher. Not seeing any company-specific news to justify the price action.

Insights On Recent Price Action

The moving average price of the stock over the past 50 days was $1.18 at the time this article was published. In the past fifty-two weeks, the stock price has been as high as $3.62 and as low as $0.29.

Benzinga Pro provides investors with timely and accurate explanations of why a stock is moving. Subscribe to receive real-time alerts explaining stock price movements. Click here to learn more.

For the latest in financial news, exclusive stories, memes follow Benzinga on Twitter, Facebook & Instagram. For the best interviews, stock market talk & videos, subscribe to our YouTube channel.

Posted-In:

Trading Ideas

Related Articles

Analyzing The Price Action In AEterna Zentaris Stock Today

The Price And Volume Action In AEterna Zentaris's Stock Today AEterna Zentaris's (NASDAQ:AEZS) stock is trading up 13.13% to a price of $1.32. The stock's current volume for the day is 13.39 million, which is approximately 47.83% of its previous 30-day average volume of 27.99 million. read more

58 Biggest Movers From Yesterday

Gainers read more

38 Stocks Moving In Monday's Mid-Day Session

Gainers read more

21 Stocks Moving in Monday's Pre-Market Session

Gainers Ocugen, Inc. (NASDAQ: OCGN) shares rose 20.6% to $11.61 in pre-market trading. Ocugen’s COVID-19 vaccine partner, India-based Bharat Biotech International Ltd., will charge as much as double its main rival AstraZeneca for its vaccines in India. read more